Found: 76
Select item for more details and to access through your institution.
METTL3 drives telomere targeting of TERRA lncRNA through m<sup>6</sup>A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma.
- Published in:
- Nucleic Acids Research, 2024, v. 52, n. 5, p. 2648, doi. 10.1093/nar/gkad1242
- By:
- Publication type:
- Article
Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat Bones.
- Published in:
- Journal of the Endocrine Society, 2024, v. 8, n. 3, p. 1, doi. 10.1210/jendso/bvae009
- By:
- Publication type:
- Article
Recent Advances in Neuroblastoma Research.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
High‐content screening of drug combinations of an mPGES‐1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 2, p. 317, doi. 10.1002/1878-0261.13502
- By:
- Publication type:
- Article
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5732, doi. 10.3390/cancers15245732
- By:
- Publication type:
- Article
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1183720
- By:
- Publication type:
- Article
The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04178-4
- By:
- Publication type:
- Article
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34965-4
- By:
- Publication type:
- Article
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 5, p. 1, doi. 10.1002/pbc.30248
- By:
- Publication type:
- Article
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma.
- Published in:
- International Journal of Oncology, 2023, v. 62, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 9, p. N.PAG, doi. 10.3390/diagnostics12092260
- By:
- Publication type:
- Article
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16455-1
- By:
- Publication type:
- Article
TC-hunter: identification of the insertion site of a transgenic gene within the host genome.
- Published in:
- BMC Genomics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12864-022-08376-0
- By:
- Publication type:
- Article
Filamin A increases aggressiveness of human neuroblastoma.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac028
- By:
- Publication type:
- Article
PPM1D Is a Therapeutic Target in Childhood Neural Tumors.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6042, doi. 10.3390/cancers13236042
- By:
- Publication type:
- Article
High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5493, doi. 10.3390/cancers13215493
- By:
- Publication type:
- Article
Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors.
- Published in:
- Nucleic Acids Research, 2021, v. 49, n. 5, p. 2509, doi. 10.1093/nar/gkab054
- By:
- Publication type:
- Article
The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-01851-w
- By:
- Publication type:
- Article
Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-78370-7
- By:
- Publication type:
- Article
Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor‐stroma drug targeting.
- Published in:
- FASEB Journal, 2020, v. 34, n. 8, p. 11101, doi. 10.1096/fj.202000684R
- By:
- Publication type:
- Article
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53.
- Published in:
- Hereditary Cancer in Clinical Practice, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s13053-020-0133-5
- By:
- Publication type:
- Article
Integrative discovery of treatments for high-risk neuroblastoma.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-13817-8
- By:
- Publication type:
- Article
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 73, doi. 10.3390/cancers12010073
- By:
- Publication type:
- Article
Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements.
- Published in:
- Genes, Chromosomes & Cancer, 2020, v. 59, n. 1, p. 50, doi. 10.1002/gcc.22790
- By:
- Publication type:
- Article
Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37240-z
- By:
- Publication type:
- Article
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 202, doi. 10.3390/cancers11020202
- By:
- Publication type:
- Article
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190970
- By:
- Publication type:
- Article
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 3, p. 1103, doi. 10.3892/ijo.2016.3349
- By:
- Publication type:
- Article
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
- Published in:
- Nature Communications, 2015, v. 6, n. 11, p. 8904, doi. 10.1038/ncomms9904
- By:
- Publication type:
- Article
Intragenic anaplastic lymphoma kinase ( ALK) rearrangements: Translocations as a novel mechanism of ALK activation in neuroblastoma tumors.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 2, p. 99, doi. 10.1002/gcc.22223
- By:
- Publication type:
- Article
Tropism of the in situ growth from biopsies of childhood neuroectodermal tumors following transplantation into experimental teratoma.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 7, p. 1630, doi. 10.1002/ijc.28498
- By:
- Publication type:
- Article
Protective Role of Humanin on Bortezomib-Induced Bone Growth Impairment in Anticancer Treatment.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 3, p. 1, doi. 10.1093/jnci/djt459
- By:
- Publication type:
- Article
Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target?
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 10, p. 2351, doi. 10.1002/ijc.28265
- By:
- Publication type:
- Article
Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene.
- Published in:
- BMC Medical Genetics, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2350-14-102
- By:
- Publication type:
- Article
ERBB3 is a marker of a ganglioneuroblastoma/ ganglioneuroma-like expression profile in neuroblastic tumours.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-70
- By:
- Publication type:
- Article
Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-231
- By:
- Publication type:
- Article
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 5, p. 1081, doi. 10.1093/carcin/bgt009
- By:
- Publication type:
- Article
Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas.
- Published in:
- Journal of Molecular Signaling, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1750-2187-8-4
- By:
- Publication type:
- Article
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 7, p. 1516, doi. 10.1002/ijc.27820
- By:
- Publication type:
- Article
Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051297
- By:
- Publication type:
- Article
Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.
- Published in:
- BMC Medical Genetics, 2012, v. 13, n. 1, p. 83, doi. 10.1186/1471-2350-13-83
- By:
- Publication type:
- Article
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.
- Published in:
- Molecular Cancer, 2012, v. 11, n. 1, p. 40, doi. 10.1186/1476-4598-11-40
- By:
- Publication type:
- Article
Autocrine Prostaglandin E<sub>2</sub> Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029331
- By:
- Publication type:
- Article
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo.
- Published in:
- International Journal of Cancer, 2011, v. 129, n. 12, p. 2958, doi. 10.1002/ijc.26268
- By:
- Publication type:
- Article
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.
- Published in:
- 2011
- By:
- Publication type:
- journal article
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
- Published in:
- Carcinogenesis, 2011, v. 32, n. 7, p. 1005, doi. 10.1093/carcin/bgr073
- By:
- Publication type:
- Article